Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India.

Y. Jagdhari (Lucknow, India), A. Verma (Lucknow, India), S. Kant (Lucknow, India), R. Mishra (Lucknow, India), K. Srivastava (Lucknow, India), . Bajpai (Lucknow, India)

Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Session: The ongoing threat of drug-resistant tuberculosis
Session type: E-poster
Number: 3334

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Jagdhari (Lucknow, India), A. Verma (Lucknow, India), S. Kant (Lucknow, India), R. Mishra (Lucknow, India), K. Srivastava (Lucknow, India), . Bajpai (Lucknow, India). Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India.. 3334

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Clinical and genotypic pattern of multidrug resistant tuberculosis isolated from extrapulmonary tuberculosis cases in tertiary care hospitals in northern India
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011

Treating extensively drug resistant tuberculosis (XDR-TB) in India
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008


Clinical profile of drug resistant tuberculosis in Pediatric Population, India.
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017


Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008


Study of drug resistance among untreated new cases of tuberculosis in Oran, Algeria
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008


Determination of DNA fingerprint and drug susceptibility patterns of Mycobacterium tuberculosis isolates from a designated area in north India
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009


Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Molecular epidemiology of multi drug resistance tuberculosis isolates from pulmonary tuberculosis cases from Lucknow, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Effect of pyrazinamide resistance on treatment results of multidrug-resistant tuberculosis cases in Aegean region, Turkey
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008


Prognosis and outcome in patients with extremely drug resistant tuberculosis from the Western Cape province, South Africa
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

Genotypic and phenotypic drug resistance of M.tuberculosis in patients registered in Moscow, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018




Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007



Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
Source: Eur Respir J, 51 (5) 1800544; 10.1183/13993003.00544-2018
Year: 2018



Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Change of the nature of micobacterial population, frequency of primary and acquired drug resistanse of M.tuberculosis in TB patients in the Republic of Dagestan
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008

Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India
Source: Eur Respir J 2002; 20: Suppl. 38, 615s
Year: 2002